Clinical trial of the efficacy and tolerability of an immunostimulant drug, composed by ribosomal fractions, in socialized paediatric patients in order to prevent recurrent respiratory infections
Clinical trial of the efficacy and tolerability of an immunostimulant drug, composed by ribosomal fractions, in socialized paediatric patients in order to prevent recurrent respiratory infections
Clinical trial of the efficacy and tolerability of an immunostimulant drug, composed by ribosomal fractions, in socialized paediatric patients in order to prevent recurrent respiratory infections
Status
Status :
Completed
Type of study
Phase IV
Min. Age
2
Years old
Max. Age
11
Years old
Gender
All
Therapeutic area :
Respiratory
Disease :
Respiratory infection
Study medication :
Ribomunyl
Phase :
Phase IV
Start Date :
August 25, 2008
End date :
December 14, 2009
Study ID :
J0022X ST 403
EudraCT/CTIS number :
2008-000487-17
Send by email